Compare UPLD & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UPLD | VNRX |
|---|---|---|
| Founded | 2010 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.6M | 22.5M |
| IPO Year | 2014 | 2012 |
| Metric | UPLD | VNRX |
|---|---|---|
| Price | $0.56 | $0.16 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $3.75 | $2.00 |
| AVG Volume (30 Days) | 290.7K | ★ 17.2M |
| Earning Date | 05-11-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 63.38 | 38.00 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $74,767,000.00 | $1,727,384.00 |
| Revenue This Year | N/A | $479.89 |
| Revenue Next Year | $1.95 | $538.41 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 6.95 | ★ 40.04 |
| 52 Week Low | $0.50 | $0.15 |
| 52 Week High | $3.90 | $0.94 |
| Indicator | UPLD | VNRX |
|---|---|---|
| Relative Strength Index (RSI) | 36.02 | 34.89 |
| Support Level | $0.50 | N/A |
| Resistance Level | $0.77 | $0.27 |
| Average True Range (ATR) | 0.08 | 0.02 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 17.72 | 9.06 |
Upland Software Inc is a software company. It provides cloud-based software applications in three categories: Knowledge Management that provides solutions designed to help organizations capture, organize, and distribute information to employees and customers. Content Lifecycle and Workflow Automation offers solutions that support document management, compliance, and process efficiency across various industries. Digital Marketing solutions that provides tools for audience engagement, campaign management, and content distribution across digital channels. Geographically, the company has operations in the U.S., United Kingdom and Canada, of which United States derives maximum revenue.
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on diagnostics and monitoring.